Early Phase I Study of Lidocaine Infusion in Pancreatic Cancer: Translational Studies in a Preclinical Model And Human Subjects
The purpose of this early phase study is to evaluate the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients undergoing robotic pancreatectomy for all types of pancreatic cancer. A prospective randomized controlled double blinded trial design will be used for the proposed study.
Study ID: 2017-1365
Trial Phase: Phase I
Trial Sponsor: University of Illinois
Therapies Used in This Trial: Lidocaine, Saline solution